Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lymphocyte depression by cancer.

A J Edwards

    Annals of the Royal College of Surgeons of England
    |May 1, 1977
    PubMed
    Summary
    This summary is machine-generated.

    A novel antilymphocytic factor in cancer appears to destroy T-cell pathways in animal models. This factor may also exist in humans, potentially explaining cancer progression and offering a therapeutic target.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Assessing the effects of transient weather conditions on airborne transmission risk in naturally ventilated hospitals.

    The Journal of hospital infection·2024
    Same author

    Diagnostic accuracy of a decision-support software for the detection of intracranial large-vessel occlusion in CT angiography.

    Clinical radiology·2023
    Same author

    'Big Data' informed drug development: a case for acceptability.

    Drug discovery today·2020
    Same author

    Identification of stable genes in the corpus luteum of lactating Holstein cows in pregnancy and luteolysis: Implications for selection of reverse-transcription quantitative PCR reference genes.

    Journal of dairy science·2020
    Same author

    Long-term impacts of rising sea temperature and sea level on shallow water coral communities over a ~40 year period.

    Scientific reports·2019
    Same author

    The free-energy barrier to hydride transfer across a dipalladium complex.

    Faraday discussions·2015
    Same journal

    A prospective randomised controlled trial comparing open and laparoscopic pyloromyotomy for infantile hypertrophic pyloric stenosis in a low-middle-income country setting.

    Annals of the Royal College of Surgeons of England·2026
    Same journal

    Designing sustainable robotic surgery for NHS scale-up: direct electricity measurement and an implementation-ready energy mitigation bundle in colorectal cancer resections.

    Annals of the Royal College of Surgeons of England·2026
    Same journal

    Trends and causes of litigation in paediatric surgery within the National Health Service (NHS) England: a 19-year analysis.

    Annals of the Royal College of Surgeons of England·2026
    Same journal

    Laparoscopic-assisted ERCP is a safe procedure with good outcomes: experience from a single high-volume upper GI unit.

    Annals of the Royal College of Surgeons of England·2026
    Same journal

    The incidence of complex regional pain syndrome following total knee arthroplasty: a prospective multicentre observational study of 1,026 patients with no cases identified according to the Budapest criteria.

    Annals of the Royal College of Surgeons of England·2026
    Same journal

    Can a generic fracture fixation assessment tool be used to assess quality of distal radius fracture fixation, and predict fixation failure?

    Annals of the Royal College of Surgeons of England·2026
    See all related articles

    Area of Science:

    • Immunology
    • Oncology
    • Pathophysiology

    Background:

    • Cancer progression involves complex host-immune interactions.
    • The role of humoral factors in cancer dissemination is not fully understood.
    • T-cell mediated immunity is crucial for controlling tumor spread.

    Purpose of the Study:

    • To investigate the role of a systemically disseminated antilymphocytic humoral factor in cancer.
    • To explore the potential presence and implications of such a factor in human cancer.
    • To assess the therapeutic potential of targeting this factor.

    Main Methods:

    • Animal models of cancer were utilized to study the effects of the humoral factor.
    • Analysis of lymphoreticular tissues in affected animals.

    Related Experiment Videos

  • Exploratory studies on cancer patients to detect a similar substance.

    • Main Results:

    • Demonstrated that a humoral factor destroys the T-cell-dependent pathway in an animal cancer model.
    • Observed disease dissemination and mortality linked to this factor's action.
    • Identified a potential correlation with similar substances in human cancer patients.

    Conclusions:

    • A systemically disseminated antilymphocytic humoral factor engages host lymphoreticular tissues in cancer.
    • This factor's action on T-cell pathways facilitates cancer dissemination and mortality.
    • The factor may be a key element in defining cancer and explaining cancer illness, presenting a potential therapeutic target.